Stage-III NSCLC: multimodality therapy for inoperable tumours
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference59 articles.
1. Role of radiotherapy in combined treatment of locally advanced non-small-cell lung cancer;Kubota;J Clin Oncol,1994
2. A randomized phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party;Sculier;Ann Oncol,1999
3. Concomitant radiochemotherapy of advanced non-small-cell lung cancer;Fietkau;Lung Cancer,2001
4. Improved survival in stage III non-small-cell lung cancer: seven year follow up of Cancer and Leukaemia Group B 8433 trial;Dillman;J Natl Cancer Inst,1996
5. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomised trial in 353 patients;Le Chevalier;J Natl Cancer Inst,1991
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of sex and age on adherence to guidelines in non-small cell lung cancer management;Cancer Treatment and Research Communications;2023
2. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer;The Pharmacogenomics Journal;2014-07-01
3. Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology;Annals of Oncology;2012-07
4. Safety and feasibility of radiotherapy treatment in elderly non-small-cell lung cancer (NSCLC) patients;Archives of Gerontology and Geriatrics;2010-03
5. Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy;Respiratory Medicine;2008-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3